Guilian Niu

6.9k total citations · 6 hit papers
19 papers, 5.7k citations indexed

About

Guilian Niu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Guilian Niu has authored 19 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Guilian Niu's work include Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cancer Mechanisms and Therapy (3 papers). Guilian Niu is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Cancer Mechanisms and Therapy (3 papers). Guilian Niu collaborates with scholars based in United States, France and Canada. Guilian Niu's co-authors include Hua Yu, Richard Jove, Drew M. Pardoll, Shumin Zhang, Tianhong Wang, Marcin Kortylewski, Maciej Kujawski, Domenico Coppola, Mei Huang and Richard Heller and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Guilian Niu

19 papers receiving 5.6k citations

Hit Papers

Constitutive Stat3 activity up-regulates VEGF expression ... 2001 2026 2009 2017 2002 2003 2005 2001 2009 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guilian Niu United States 16 3.6k 2.6k 2.0k 1.1k 878 19 5.7k
Tammy Bowman United States 16 3.9k 1.1× 2.9k 1.1× 1.1k 0.6× 894 0.8× 1.1k 1.2× 19 5.4k
Ralf Buettner United States 24 2.9k 0.8× 2.9k 1.1× 1.1k 0.6× 1.1k 0.9× 834 0.9× 63 5.6k
Heehyoung Lee United States 24 3.0k 0.8× 3.0k 1.2× 2.1k 1.1× 1.6k 1.5× 717 0.8× 26 6.2k
Fabrice Gouilleux France 42 3.9k 1.1× 2.6k 1.0× 2.3k 1.2× 1.1k 0.9× 434 0.5× 88 6.6k
Lindsey D. Mayo United States 28 2.4k 0.7× 4.6k 1.8× 934 0.5× 1.5k 1.4× 437 0.5× 61 6.3k
Kaoru Kiguchi United States 36 1.9k 0.5× 3.0k 1.2× 1.1k 0.5× 832 0.7× 548 0.6× 77 5.3k
Geeta Devgan United States 12 2.3k 0.6× 1.6k 0.6× 908 0.4× 533 0.5× 562 0.6× 25 3.3k
Lanxi Song United States 20 2.1k 0.6× 2.2k 0.8× 615 0.3× 664 0.6× 517 0.6× 23 3.9k
Luni Emdad United States 41 1.9k 0.5× 3.1k 1.2× 857 0.4× 909 0.8× 1.5k 1.7× 120 5.4k
Daoyan Wei United States 43 2.0k 0.6× 4.3k 1.7× 632 0.3× 1.7k 1.5× 547 0.6× 75 6.2k

Countries citing papers authored by Guilian Niu

Since Specialization
Citations

This map shows the geographic impact of Guilian Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilian Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilian Niu more than expected).

Fields of papers citing papers by Guilian Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilian Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilian Niu. The network helps show where Guilian Niu may publish in the future.

Co-authorship network of co-authors of Guilian Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Guilian Niu. A scholar is included among the top collaborators of Guilian Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guilian Niu. Guilian Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lee, Heehyoung, Andreas Herrmann, Jiehui Deng, et al.. (2009). Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors. Cancer Cell. 15(4). 283–293. 558 indexed citations breakdown →
2.
Cho, Hyun-Il, et al.. (2008). Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors. Cancer Immunology Immunotherapy. 57(11). 1695–1703. 15 indexed citations
3.
Niu, Guilian, Jiehui Deng, Yihong Ma, et al.. (2008). Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells. Molecular Cancer Research. 6(7). 1099–1105. 151 indexed citations
4.
Lopez, Dayami, Guilian Niu, Philippe Huber, & W. Bradford Carter. (2008). Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Archives of Biochemistry and Biophysics. 482(1-2). 77–82. 58 indexed citations
6.
Carter, W. Bradford, et al.. (2007). Mechanisms of HER2-Induced Endothelial Cell Retraction. Annals of Surgical Oncology. 14(10). 2971–2978. 7 indexed citations
7.
Xu, Qing, Sungman Park, Guilian Niu, et al.. (2005). Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 24(36). 5552–5560. 489 indexed citations breakdown →
8.
Burdelya, Lyudmila G., Maciej Kujawski, Guilian Niu, et al.. (2005). Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects. The Journal of Immunology. 174(7). 3925–3931. 114 indexed citations
9.
Kortylewski, Marcin, Maciej Kujawski, Tianhong Wang, et al.. (2005). Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nature Medicine. 11(12). 1314–1321. 813 indexed citations breakdown →
10.
Vultur, Adina, Rozanne Arulanandam, James Turkson, et al.. (2005). Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen. Molecular Biology of the Cell. 16(8). 3832–3846. 45 indexed citations
11.
Niu, Guilian, Kenneth L. Wright, Yihong Ma, et al.. (2005). Role of Stat3 in Regulating p53 Expression and Function. Molecular and Cellular Biology. 25(17). 7432–7440. 332 indexed citations
12.
Wang, Tianhong, Guilian Niu, Marcin Kortylewski, et al.. (2003). Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine. 10(1). 48–54. 923 indexed citations breakdown →
13.
Fang, Weigang, Hongmei Li, Lingling Kong, et al.. (2003). [Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs].. PubMed. 35(4). 441–3. 12 indexed citations
14.
Niu, Guilian, Kenneth L. Wright, Mei Huang, et al.. (2002). Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21(13). 2000–2008. 1019 indexed citations breakdown →
15.
Huang, Mei, Jay F. Dorsey, Ramadevi Nimmanapalli, et al.. (2002). Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene. 21(57). 8804–8816. 102 indexed citations
16.
Niu, Guilian, Tammy Bowman, Mei Huang, et al.. (2002). Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene. 21(46). 7001–7010. 355 indexed citations
17.
Garcia, Roy, Tammy Bowman, Guilian Niu, et al.. (2001). Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene. 20(20). 2499–2513. 654 indexed citations breakdown →
18.
Niu, Guilian, Jun Tan, Joel G. Turner, et al.. (2000). Bing De Ling, a Chinese Herbal Formula, Stimulates Multifaceted Immunologic Responses in Mice. DNA and Cell Biology. 19(8). 515–520. 5 indexed citations
19.
Tan, Jun, Joel G. Turner, Guilian Niu, et al.. (1999). Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response. Cancer Gene Therapy. 6(4). 331–339. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026